SUBSCRIBE
SUBSCRIBE
News   Drug Development

Vertex Pharmaceuticals (MA), Johnson & Johnson Hepatitis C Drug Works After Others Fail Like Merck & Co., Inc.'s Boceprevir

September 8, 2010 | 
1 min read
Bloomberg -- Vertex Pharmaceuticals Inc.’s most advanced experimental drug, in development with Johnson & Johnson, worked in patients with hepatitis C who didn’t respond to other treatment, a study found.
Clinical research Phase III
Johnson & Johnson Family of Companies Merck & Co. Vertex Pharmaceuticals
MORE ON THIS TOPIC
Sep 17, 2020 Fremont / CA / USA - Novo Nordisk headquarters in Silicon Valley; Novo Nordisk A/S is a Danish multinational pharmaceutical company
Cardiovascular disease
Novo’s Wegovy Cuts Cardio Risk by 57% Versus Tirzepatide
September 2, 2025
 · 
2 min read
 · 
Tristan Manalac
Indianapolis, U.S. - April 16, 2016: Eli Lilly and Company World Headquarters. Lilly makes Medicines and Pharmaceuticals VII
Obesity
Lilly Ends Two Mid-Stage Trials for Second Obesity Asset
September 2, 2025
 · 
2 min read
 · 
Tristan Manalac
Allschwil, Switzerland - 09. May 2022: The modern architecture of business center of Johnson and Johnson, which is a world famous company for pharmaceuticals and biotechnology.
Immunology and inflammation
J&J Ends Rheumatoid Arthritis Program After Disappointing Mid-Stage Data
August 29, 2025
 · 
2 min read
 · 
Tristan Manalac
vector illustration arrows miss the target board, concept of lost in focus, failure, fail, mistake
Alzheimer’s
Prothena’s Alzheimer’s Drug Comes With Familiar Side Effect in Phase I Test
August 28, 2025
 · 
2 min read
 · 
Annalee Armstrong